TREM1 and familial pancreatic carcinoma: Preclinical study showed that blockade of TREM1 specifically suppresses key cytokines and thereby inhibited tumor growth in human pancreatic cancer xenografts and prolonged the survival of mice (Shen and Sigalov, 2017).